29 June 2025
Orforglipron can offer a new oral option for managing weight loss and blood sugar in type 2 diabetes treatment.
4 March 2025
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.